Whitney & Co’s PRA Health Sciences, Inc. PRAH Stock Holding History

Whitney & Co’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21	Closed	-$2K	–	517
2018 Q3	$2K	Buy	+21	New	+$2.19K	﹤0.01%	490

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Whitney & Co's PRAH Position: Q4 2018 in Review

Whitney & Co sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2018, closing a stake of 21 shares — an estimated $2K sold.

Whitney & Co first reported a position in PRAH in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 334 funds tracked by Wall St. Rank hold PRAH as of Q4 2018.

Whitney & Co reported no remaining PRA Health Sciences, Inc. position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 21 PRA Health Sciences, Inc. shares in Q4 2018, an estimated $2K.
Whitney & Co first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 1 quarter.
Whitney & Co's PRA Health Sciences, Inc. position peaked at $2K in Q3 2018.
334 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.